Ikarian Capital, LLC - 30 Sep 2025 SCHEDULE 13G Report for Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX)

Filing Manager: Ikarian Capital, LLC
Reporting Manager: Ikarian Capital, LLC
Security: Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: TENX
Shares outstanding: 4,564,151 shares
Disclosed Ownership: 967,600 shares
Ownership: 21%
Form type: SCHEDULE 13G
Filing time: 07 Oct 2025, 16:15:35 UTC
Date of event: 30 Sep 2025
Next filing: 05 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ikarian Capital, LLC	21%	967,600	0	967,600	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager
Neil Shahrestani	21%	967,600	0	967,600	/s/ Neil Shahrestani	Neil Shahrestani